Correspondence

Letter to the ACMD to review GHB and GBL

Letter from the Home Secretary asking the Advisory Council on the Misuse of Drugs to review the classification of GHB and GBL.

• From: Home Office and The Rt Hon Priti Patel MP
• Published: 6 January 2020

This was published under the 2019 to 2022 Johnson Conservative government

Documents

Letter from the Home Secretary to the Chair of the Advisory Council on the Misuse of Drugs (accessible version)

HTML

Letter from the Home Secretary to the Chair of the Advisory Council on the Misuse of Drugs

PDF, 71.8 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The letter from the Home Secretary, Rt Hon Priti Patel MP, asks the Advisory Council on the Misuse of Drugs to review the classification of gamma-hydroxybutyric acid (GHB) and gamma-butyrolactone (GBL) and closely related compounds under the Misuse of Drugs Act 1971 and the scheduling of both drugs under the Misuse of Drugs Regulations 2001.

Published 6 January 2020